Endocannabinoid signaling in glioma



Downloads per month over past year

Costas Insua, Carlos and Guzmán, Manuel (2022) Endocannabinoid signaling in glioma. Glia . ISSN 0894-1491

[thumbnail of Glia - 2022 - Costas‐Insua - Endocannabinoid signaling in glioma.pdf]
Creative Commons Attribution.


Official URL: https://doi.org/10.1002/glia.24173


High-grade gliomas constitute the most frequent and aggressive form of primarybrain cancer in adults. These tumors express cannabinoid CB1and CB2receptors, aswell as other elements of the endocannabinoid system. Accruing preclinical evidencesupports that pharmacological activation of cannabinoid receptors located on gliomacells exerts overt anti-tumoral effects by modulating key intracellular signaling path-ways. The mechanism of this cannabinoid receptor-evoked anti-tumoral activity inexperimental models of glioma is intricate and may involve an inhibition not only ofcancer cell survival/proliferation, but also of invasiveness, angiogenesis, and the stemcell-like properties of cancer cells, thereby affecting the complex tumor microenvi-ronment. However, the precise biological role of the endocannabinoid system in thegeneration and progression of glioma seems very context-dependent and remainslargely unknown. Increasing our basic knowledge on how (endo)cannabinoids act onglioma cells could help to optimize experimental cannabinoid-based anti-tumoraltherapies, as well as the preliminary clinical testing that is currently underway.

Item Type:Article
Additional Information:

CRUE-CSIC (Acuerdos Transformativos 2022)

Uncontrolled Keywords:anti-tumoral therapy, apoptosis, cannabinoid, G protein-coupled receptor, glioma, metabolism, tumor microenvironment
Subjects:Sciences > Chemistry > Molecular biology
Sciences > Chemistry > Biochemistry
Medical sciences > Medicine
ID Code:72624
Deposited On:14 Jun 2022 10:03
Last Modified:14 Jun 2022 11:14

Origin of downloads

Repository Staff Only: item control page